Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsight
Ascendis Pharma A/S - American Depositary Shares (ASND)
Last ascendis pharma a/s - american depositary shares earnings: 11/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ascendispharma.com
Company Research
Source: PR Newswire
The hormone replacement therapy market is witnessing substantial growth due to the rising occurrence of hormonal and targeted conditions such as menopause and osteoporosis, coupled with the growing elderly population, which is fueling demand for HRT. Increased awareness about menopause management, interest in regenerative medicine—including anti-aging and reproductive therapies—a rise in drug approvals, new product launches, and the active involvement of key market players underscore the vibrant nature of the HRT market, which is expected to expand significantly between 2024 and 2030.LAS VEGAS, Sept. 26, 2024 /PRNewswire/ -- DelveInsight's Hormone Replacement Therapy Market Insights report provides the current and forecast market analysis, individual leading hormone replacement therapy companies' market shares, challenges, hormone replacement therapy market drivers, barriers, trends, and key market hormone replacement therapy companies in the market.Key Takeaways from the Hormone Repl
Show less
Read more
Impact Snapshot
Event Time:
ASND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASND alerts
High impacting Ascendis Pharma A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ASND
News
- Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsightPR Newswire
- Citi's ‘Catalyst Watch' list of U.S. stocks for crowding analysis [Seeking Alpha]Seeking Alpha
- Ascendis Pharma A/S (NASDAQ: ASND) had its price target raised by analysts at Bank of America Co. from $175.00 to $191.00. They now have a "buy" rating on the stock.MarketBeat
- Ascendis Pharma A/S Announces Pricing of Public Offering of ADSsGlobeNewswire
- Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of DirectorsGlobeNewswire
ASND
Earnings
- 9/3/24 - Miss
ASND
Sec Filings
- 9/27/24 - Form 6-K
- 9/23/24 - Form 6-K
- 9/20/24 - Form 424B5
- ASND's page on the SEC website